Background: Emerging evidence indicates that the transcription factor nuclear factor-E2-related
factor 2 (Nrf2) plays an essential role in cellular defense against oxidative stress; its activation has been related
Objective: Here, we investigated the role of Nrf2 in improving the efficacy of methyl pyropheophorbide-amediated
photodynamic therapy (Mppa-PDT) via the downregulation of Nrf2.
Method: Human ovarian cancer A2780 cells and SKOV3 cells were treated with Mppa-PDT and siRNA
transfection was performed to inhibit Nrf2. After treated with siRNA and Mppa-PDT, the cell viability was
examined with CCK-8 assay; cell apoptosis was detected tested by flow cytometry with Annexin V-FITC/PI;
the celluar reactive oxygen species (ROS) and mitochondrial membrane potential were measured with DCFHDA
and JC-1 staining; expression of protein was assessed by western blot analysis.
Results: We found that Nrf2 translocated from the cytoplasm to the nucleus in vitro and in vivo, and the
expression of Nrf2 and P-Nrf2 increased through a possible mechanism regulated by mitogen-activated protein
kinase (MAPK) after Mppa-PDT treatment. Furthermore, cytotoxicity and apoptosis induced by Mppa-PDT
increased after Nrf2down-regulation. Nrf2 down -regulation increased reactive oxygen species (ROS) levels by
attenuating antioxidants or pumping Mppa out of cells,which resulted from the inhibition of Nrf2-HO-1 or Nrf2-
ABCG2 signaling. In addition, SKOV3 cells exhibited increased resistance to Mppa-PDT, and the expression
levels of P-Nrf2 and ABCG2 were higher in SKOV3 cells than in A2780 cells, suggesting that Nrf2-ABCG2
signaling might be involved in the intrinsic resistanceto Mppa-PDT.
Conclusion: These results provided evidence that Nrf2 down-regulation can enhance the effect of Mppa-PDT.